Superselective Adrenal Arterial Embolization Versus Oral Spironolactone for Treatment of Idiopathic Hyperaldosteronism
Clinical trial NCT07328230 · RECRUITING
Trial details
- NCT number
- NCT07328230
- Sponsor
- Chinese Academy of Medical Sciences, Fuwai Hospital
- Status
- RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2022-08-01
- Primary completion
- 2025-12-31
- Enrollment
- 172
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.